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Summary
Objective: Matrilin-3 is a member of the recently described matrilin family of extracellular matrix proteins containing von Willebrand factor
A-like domains. The matrilin-3 subunit can form homo-tetramers as well as hetero-oligomers together with subunits of matrilin-1 (cartilage
matrix protein). It has a restricted tissue distribution and is strongly expressed in growing skeletal tissues. Detailed information on expression
and distribution of extracellular matrix proteins is important to understand cartilage function in health and in disease like osteoarthritis (OA).
Methods: Normal and osteoarthritic cartilage were systematically analysed for matrilin-3 expression, using immunohistochemistry, Western
blot analysis, in situ hybridization, and quantitative PCR.
Results: Our results indicate that matrilin-3 is a mandatory component of mature articular cartilage with its expression being restricted to
chondrocytes from the tangential zone and the upper middle cartilage zone. Osteoarthritic cartilage samples with only moderate
morphological osteoarthritic degenerations have elevated levels of matrilin-3 mRNA. In parallel, we found an increased deposition of
matrilin-3 protein in the cartilage matrix. Matrilin-3 staining was diffusely distributed in the cartilage matrix, with no cellular staining being
detectable. In cartilage samples with minor osteoarthritic lesions, matrilin-3 deposition was restricted to the middle zone and to the upper
deep zone. A strong correlation was found between enhanced matrilin-3 gene and protein expression and the extent of tissue damage.
Sections with severe osteoarthritic degeneration showed the highest amount of matrilin-3 mRNA, strong signals in in situ hybridization, and
prominent protein deposition in the middle and deep cartilage zone.
Conclusion: We conclude that matrilin-3 is an integral component of human articular cartilage matrix and that the enhanced expression of
matrilin-3 in OA may be a cellular response to the modified microenvironment in the disease. © 2002 OsteoArthritis Research Society
International
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Osteoarthritis (OA) is a degenerative joint disease, involv-
ing mechanical, biochemical, hormonal, and genetic fac-
tors. The relative importance of these factors varies in the
disease process and cannot be defined easily in patients
with OA. The continuous loss of the articular cartilage
matrix is the prominent feature of the progressive osteo-
arthritic process. The cartilage of articular joints is an
extremely specialized tissue which enables a stable and
smooth movement of the joint surfaces and, equally import-
ant, the dissipation of mechanical load under physiological
conditions. Type II collagen and aggrecan, the two most
abundant components of the cartilage extracellular matrix,
are major contributors to these properties and have, there-
fore, been analysed extensively1,2. Cartilage collagen
fibrils form highly organized three-dimensional structures253responsible for the tissue stiffness. Under-hydrated proteo-
glycans within this meshwork contribute to the compen-
sation of the load stress and are mainly responsible for the
visco-elastic properties of the articular cartilage matrix.
Additional components of the extracellular matrix such as
type VI collagen, are implicated as being important in the
mechano-protective filament structures that surround the
chondrocytes3. Other cartilage proteins and proteoglycans
such as COMP, CILP, fibronectin, and decorin have puta-
tive functions in cell-matrix and matrix-matrix interactions
(reviewed in Neame et al.4).
Matrilin-3 belongs to a family of extracellular matrix
proteins with members that share similarities in their modu-
lar compositions (reviewed in Dea´k et al.5). Matrilin-1
(earlier called cartilage matrix protein or CMP), -2, -3, and
-4 share an N-terminal signal peptide domain, often fol-
lowed by a short stretch of positively charged amino acids
and a von Willebrand factor A (vWFA)-like domain. Close
to the vWFA-like domain, one or several epidermal growth
factor (EGF)-like domains are found. The number of
EGF-like domains varies among the matrilins, with four
EGF-like domains found in matrilin-36–8. A second vWFA-
like domain occurs in matrilin-1, -2, and –4, however in
matrilin-3 this domain is absent7,9. At the C-terminal end
of the molecule, all matrilins carry a coil-coiled -helical
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CARTILAGE/BONE SAMPLES
Thirty osteoarthritic cartilage/bone samples were
obtained from 17 patients with primary OA (54- to 75
year-old donors) undergoing total knee replacement.
Clinical data were carefully reviewed to exclude any forms
of secondary OA and inflammatory joint diseases like
rheumatoid arthritis. Normal cartilage was collected from
five human knees at the time of autopsy within 18 h after
death (34- to 56-year-old donors). In these five knees, the
femorotibial and patellafemoral joint faces were completely
free from any signs of OA. Video printouts were used
to document the region where samples were taken.
Osteoarthritic changes were classified histomorphologi-
cally, using the grading system of Mankin2. Mankin score 0:
normal cartilage with a smooth surface and a regular zonal
distribution of the chondrocytes. Mankin score 1–4: carti-
lage surface shows fibrillations and a superficial loss of
proteoglycans (safranin-O staining); the zonal structure is
intact. Mankin score 5–8: Cartilage samples have clefts
reaching down to the middle cartilage zone; clusters of
proliferating chondrocytes are present. Mankin score ≥9:
cartilage samples are severely affected; clefts are reaching
down to the deep zone; the tangential zone is lost and
chondrocyte clusters are present. Five samples (Mankinscore 0), eight samples (Mankin score 1–4), 12 samples
(Mankin score 5–8), and 10 samples (Mankin score ≥9)
were included in the study. This investigation has been
approved by the local ethics commission (application No.
2078).
Cartilage/bone samples of 1 cm thickness with a carti-
lage surface of about 2.0×0.5 cm were incubated in freshly
prepared paraformaldehyde, 4% (w/v), buffered with
0.01 M sodium phosphate, pH 7.4, containing 0.14 M NaCl
(PBS) for 12 h at 4°C. The tissue samples were decalcified
in diethyl-pyrocarbonate (DEPC)-treated 0.2 M EDTA,
pH 8.0, for several weeks at 4°C. The buffer was changed
twice a week. Tissue specimens were then dehydrated
through graded concentrations of ethanol and xylene and
finally embedded in paraffin. Cartilage/bone and cartilage
sections (5 m) were mounted on glass slides, precoated
with 1% (v/v) 3-aminopropyl triethoxysilane, and heated for
90 min at 65°C.Table I
Primers used for matrilin-3 riboprobe preparation (#1 and #2) and for quantitative competitive PCR (#3 and #3 ′)
Primer pair Primer sequence PCR products
(bp)
#1 (forward) 5′cat gtt cag cca ctg agg aa 785
#1 (reverse) 5′cag aat gaa tta aaa atg gca atg
#2 (forward) 5′cag gtg ttt gca aga gca ga 529
#2 (reverse) 5′acc cca tag gtc tcc acg ta
#3 (forward) 5′cat gtt cag cca ctg agg aa 525
#3 (reverse) 5′aac agg tgt gca aaa gaa tgc
#3′ (reverse) 5′aac agg tgt gca aaa gaa tgc gca att taa cga tgt att tgt cca 202PREPARATION OF THE MATRILIN-3 RNA PROBE
Total RNA was extracted from human knee cartilage.
0.5 g of cartilage was frozen in liquid nitrogen and pulver-
ized using a stainless steel mortar and pestle. Extraction
was performed using cold guanidine isothiocyanate buffer
and a subsequent extraction with phenol17. 0.5 g of total
RNA was transcribed into single-stranded cDNA using AMV
reverse transcriptase (Roche, Mannheim, Germany) and
Oligo-p(dT)15 as a primer according to the manufacturer’s
protocol (Roche). Two double-stranded cDNA fragments
were generated by PCR using primer pair 1 and 2 (Table I).
The primer pair 1 spans 785 bases (position 1103–2087) of
the coding region of the human matrilin-3 cDNA (Accession
No. AJ224741)8. The primer pair 2 spans 529 bases
(position 238–766) of the coding region of the human
matrilin-3 cDNA. After standard PCR (annealing tempera-
ture: 60°C, 35 cycles), a T7 promoter-adapter (Ambion,
Austin, TX, U.S.A) was ligated non-directionally. The tran-
scription template was performed using a second PCR with
the gene-specific forward primer and a T7 promoter-
adapter primer (Ambion). The amplified PCR products were
checked by sequencing (MWG, Ebersberg, Germany).
For in vitro transcription and labeling, 100 ng of the
template was transcribed in 1 mM ATP, 1 mM CTP, 1 mM
GTP, 0.65 mM UTP and 0.35 mM digoxigenin-11-UTP in
40 mM Tris-HCl, pH 8.0, 6 mM MgCl2, 10 mM dithiothreitol,
2 mM spermidine and 40 U T7 RNA-Polymerase (Roche).
The components were incubated for 2 h at 37°C. Template
DNA was removed with 20 U DNase I (Roche). The
reaction was stopped by adding 2 l 0.2 M EDTA pH 8.0.
RNA was further purified by ethanol precipitation and
resuspended in 100 l DEPC-treated H O. Transcriptsdomain, responsible for the assembly into oligomeric
aggregates (for refs see Dea´k et al.5).
Matrilin-3 is a recently discovered matrilin with a putative
function in the assembly of the cartilage extracellular
matrix6,7. It is expressed in growing skeletal tissues of man,
mouse and chicken7,8,10,11. In 6-week-old mice, matrilin-3
mRNA is mainly found in the epiphyseal growth plate and
in the bone forming cells10. The expression pattern of
matrilin-3 in the growth plate is similar to that of matrilin-112.
Therefore, expression of matrilin-3 indicates a role in the
development of skeletal tissues. However, in normal adult
articular cartilage, matrilin-1 expression is very limited or
absent13,14.
The expression of matrilin-3 in osteoarthritic cartilage
has not been previously studied. In the progress of OA,
articular cartilage chondrocytes behave similarly to those in
the epiphyseal growth plate in that they differentiate,
undergo hypertrophy, and, in a further differentiation
step, express a posthypertrophic phenotype15,16. We have
systematically analysed the expression of matrilin-3 mRNA
and protein in normal and osteoarthritic cartilage to define
its role in the physiology and pathophysiology of osteo-
arthritic cartilage. Our results contribute to a better
understanding of the complex matrix interactions in OA.2
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by denaturing gel electrophoresis followed by Northern
blotting and digoxigenin detection using the DIG-nucleic-
acid-detection-kit (Roche). For in situ hybridization,
approximately 100 ng of matrilin-3 antisense or sense
riboprobe were used for each tissue section. Immediately
before use, riboprobes were incubated for 10 min at 96°C
followed by 2 min at 4°C.IN SITU HYBRIDIZATION
Tissue sections were deparaffinized in xylene and rehy-
drated through graded concentrations of ethanol (100% to
50%). Sections were incubated with proteinase K, 50 g/ml
in 100 mM Tris, pH 7.5, with 50 mM EDTA, for 15 min at
37°C and postfixed in 4% (w/v) paraformaldehyde/PBS for
1 min. Sections were briefly washed in DEPC- treated
double distilled water and acetylated twice for 5 min in
0.1 M triethanolamine by adding 0.3% (v/v) acetic acid
anhydride. Sections were briefly incubated in PBS, dehy-
drated using increasing concentrations of ethanol (50% to
100%), and air-dried under dust-free conditions. Sections
were prehybridized with hybridization buffer containing
50% formamide (v/v), 10% dextran (w/v), 0.026%
Denhardt’s solution (v/v), 0.5 mg/ml fish sperm DNA
(Roche), 0.8 M NaCl, 0.6 mM DTT, 0.6 mM EDTA, 7 mM
Tris, pH 7.5. They were carefully covered with Parafilm
(Sigma, Munich, Germany) and prehybridization carried out
for 1 h at 55°C. 50 l of the hybridization solution containing
100 ng of the matrilin-3 probe was applied to each section.
The sections were then covered with Parafilm and incu-
bated in a humidified chamber overnight at 55°C. Sense
strand in situ hybridization was also performed with the
matrilin-3 probes using similar conditions as for the anti-
sense hybridization. After hybridization, the sections were
washed with 2×sodium chloride, sodium citrate (SSC),
50% formamide for 30 min at 52°C and with TNE buffer
(10 mM Tris, pH 7.5, 0.5 M NaCl, 1 mM EDTA) at 37°C for
10 min. Non-specific binding was abolished by RNase
treatment (RNase A, 5 g/ml, in 5 mM Tris, 0.5 M NaCl,
pH 7.5, 5 mM EDTA) for 1 h at 37°C. Sections were briefly
washed in TNE at 37°C, and then washed in 2×SSC for
20 min at 52°C, and two times in 0.2×SSC for 20 min at
52°C. Detection of bound probes was performed using a
commercially available nucleic-acid-detection-kit (Roche).
Briefly, sections were incubated in blocking solution con-
taining 10% (v/v) fetal calf serum. After blocking, an anti-
digoxigenin alkaline phosphatase-labeled antibody was
added and bound antibodies were detected after incubation
with the substrate solution (X-phosphate/NBT) overnight.
Sections were counterstained with 0.5% (w/v) light green
(Merck, Darmstadt, Germany) in 5% (v/v) ethanol and
mounted in Entellan (Merck).
Nucleic acid sequence homologies were tested using the
FASTA program of the EMBL, Heidelberg, Germany.
Homologies to listed RNA sequences were less than 55%
within an overlapping region of maximal 500 base pairs for
the 785 bp probe and less then 60% within an overlapping
region of maximal 504 base pairs for the 529 bp probe. The
specificity of the probes was controlled by using two
different matrilin-3 mRNA probes, which were directed
against different portions of the same transcript. Further
controls for both matrilin-3 mRNA probes were performed
by blocking the signal using unlabeled riboprobes prior
the labeled probe. Integrity of the mRNA in cartilage and
bone was assessed using a 115 base pair antisenseriboprobe for the human 28S RNA (nucleotide 4400–4415,
Accession No. M11167, Ambion, Austin, U.S.A.). The
hybridization protocol was similar to those used for the
matrilin-3 probes, however probe concentration and
hybridization temperature was reduced (10 ng per section
at 43°C).IMMUNOLOCALIZATION OF MATRILIN-3
Tissue sections were deparaffinized in xylene and rehy-
drated. Human cartilage/bone sections were digested with
2 mg/ml hyaluronidase (Merck) in PBS, pH 5.5, for 15 min
at 37°C and with 1 mg/ml pronase (Roche) in PBS, pH 7.4,
for 30 min at 37°C. After two washes in PBS, sections were
incubated in PBS containing 5% (w/v) bovine serum albu-
min (BSA). The sections were incubated with affinity puri-
fied polyclonal antibodies against matrilin-3 in 1% (w/v)
BSA/PBS and incubated overnight at 4°C. The specificity of
these antibodies has been demonstrated elsewhere10.
After three washes in tris-buffered saline (TBS), a biotin-
labeled donkey anti-rabbit IgG antibody (Dianova,
Hamburg, Germany) diluted 1:200 in 1% (w/v) BSA/TBS
was added and incubated for 30 min at room temperature.
After that, alkaline-phosphatase-labeled streptavidin was
added according to the protocol of the manufacturer (Dako,
Hamburg, Germany). After three short washes in TBS,
bound antibodies were visualized using Fast Red (Sigma)
as a color substrate. To exclude non-specific background
staining, sections were incubated with affinity purified rabbit
IgG (Dako), 1:20 000 in 1% (w/v) BSA/PBS and immuno-
histochemical detection was performed as described
above.WESTERN BLOT ANALYSIS
Cartilage extracts were obtained from normal (N=4) and
osteoarthritic samples (N=6), taken from the femoral con-
dyles of human knee joints. Hyaline cartilage was peeled
off from the underlying bone and homogenized at 4°C with
an Ultraturrax homogenizer (Jahnke and Kunkel, Germany)
in 4 M guanidinium chloride, 50 mM sodium acetate,
pH 5.8, containing proteinase inhibitors (10 mM N-
ethylmaleimide, 10 mM phenyl methane sulfonylfluoride,
10 mM benzamidine hydrochloride). After 48 h of stirring at
4°C the insoluble material was removed by centrifugation at
13,000 g, 4°C, for 1 h. Proteins were separated from pro-
teoglycans using an equilibrium centrifugation in a self-
forming cesium chloride gradient. The extract was adjusted
to a density of 1.35 mg/ml by the addition of solid cesium
chloride. A Kontron swing-out rotor (TST 28.38) equipped
with polyallomer thick wall tubes (38.5 ml) was used and
centrifugation was done for 70 h (105,000×g; rav=
23.89 cm) at 18°C. The gradient was divided into four
equal portions from which the two top fractions were pooled
and dialysed twice against 50 mM sodium acetate, pH 5.8,
containing proteinase inhibitors (see above) and then
against distilled water at 4°C for 12 h. Samples correspond-
ing to 15 g protein were lyophilized and redissolved in 1%
SDS/sample buffer without dithiothreitol, denatured at
95°C for 5 min and analysed in a vertical SDS gel electro-
phoresis unit (Pharmacia, Freiburg, Germany) using a
4–22% gradient polyacrylamide gel in a discontinuous
buffer system (0.8 mA/cm2). Proteins were blotted onto a
nitrocellulose membrane for 2 h by using a constant current
of 100 mA. Blotting efficiency and protein loading were
controlled by reversible staining with Ponceau S-Red.
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membrane was destained with distilled water and incu-
bated in TBS containing 1% non-fat dry milk blocking
solution (Roche) for 1 h at room temperature. The poly-
clonal matrilin-3 antibody was diluted in 0.5% blocking
solution and incubated for 2 h at room temperature. The
membrane was extensively washed in TBS containing
0.1% Tween (TBST) followed by washing in 0.1% blocking
solution. A horseradish peroxidase-conjugated goat anti-
rabbit antibody (Dianova) was used at 1:1000 dilution
in 0.5% blocking solution after 30 min of incubation at
room temperature and appropriate washing in TBST.
Chemiluminescence detection was carried out according to
the manufacturer’s protocol (Roche). Light emissions were
visualized on a light sensitive X-ray film (Roche) after 5 to
10 min exposure time.Fig. 1. Preparation of the internal standard (competitor) for quantitative determination of matrilin-3 mRNA. The first 21 bases (reading from
the 5′ end) of primer #3′ and the following 24 bases are complementary to two different regions within the matrilin-3 cDNA. Binding results
in a loop formation, leading to a 50 bp deletion in the PCR fragment. The mutated competitor was purified by electrophoretic size fractioning
after gel electrophoresis.QUANTITATIVE DETERMINATION OF MATRILIN-3 mRNA USING
COMPETITIVE PCR
Total RNA was extracted from human knee cartilage
and 100 ng transcribed into cDNA as described above.
Competitive quantitative PCR (cq-PCR) was carried out
using a modification of the protocol of Riedy et al.18 and
Ko¨hler et al.19 Quantification of the matrilin-3 mRNA was
based on the competitive amplification of matrilin-3 cDNA
and an internal cDNA standard (=competitor) with identical
primer binding sites. The competitor was generated by
PCR, using final concentrations of 0.2 M of primer #3 and
0.2 M of primer #3′ (Table I), 1.5 mM MgCl2, 10 mM Tris
pH 8.3, 50 mM KCl pH 8.3, and 2.5U/100 l Taq DNA
Polymerase (Roche). Temperature cycling profile was 94°C
for 1 min, 55°C annealing for 1 min and 72°C extension for
2 min. Binding of primer #3′ causes the formation of a loop
on the sense strand (Fig. 1). In the following PCR reaction,
the Taq polymerase elongates primer #3′ resulting in a
cDNA having a 50 bp deletion within the PCR fragment.
30 l of the PCR reaction mixture was size fractionated
on a 2% agarose gel, following staining with ethidium
bromide. The 202 bp competitor was excised from the gel
and purified (gel extraction kit, Qiagen, Hilden, Germany).
The concentration of the competitor was determined by
measuring the absorbance of aliquots at 260 nm. For
cq-PCR the PCR reaction mixture (25 l) contained 1 l ofeach patient’s cartilage cDNA (equivalent to 5 ng total
RNA), 1 mM deoxynucleotide mix (Roche), 0.2 M primer
#3 forward, 0.2 M primer #3 reverse, 1.5 mM MgCl2,
10 mM Tris pH 8.3, 50 mM KCl, pH 8.3. One cycle with
94°C, 30 s and 60°C, 30 s was performed. After that,
defined amounts of competitor were added to each tube at
room temperature (0.6, 2.4, 9.8, 39, 156, 625, and 2500 fg),
tubes were replaced into the thermal cycler at 72°C
and 0.625 U Taq DNA Polymerase (Roche) was added.
Incubation was continued for 1 min at 72° to synthesize a
double stranded cDNA. PCR was then performed by 28
cycles of denaturation at 94°C for 30 s, annealing at 60°C
for 30 s and elongation at 72°C for 60 s, ending with a final
incubation at 72°C for 10 min to complete polymerization.
10 l of the PCR product was size fractioned on a
2% agarose gel and visualized using ethidium bromide
staining. The gel was recorded by video camera and the
intensities of the amplified fragments were calculated
using the Scion image software tool (Scion Corporation,
Frederick, U.S.A.). To correct for differences in molecular
weight, competitor values and matrilin-3 cDNA values were
divided by their base pair numbers20.
The ratio of competitor intensity to matrilin-3 intensity vs
the known amount of competitor cDNA was plotted in a
log-log scale. At the point where competitor intensity and
matrilin-3 intensity are in equivalence [log (ratio)=1], the
amount of matrilin-3 cDNA is equal to the known amount of
competitor template. Results are expressed in femtogram
of matrilin-3 cDNA/ng RNA. For control, amplification was
performed using 5 ng of the RNA preparation instead of
reversed transcribed cDNA to exclude unspecific amplifica-
tion of DNA. The grading of the cartilage samples from
which mRNA was extracted was done by histomorphologi-
cal validation of the adjacent areas using the Mankin score.
The specificity of the PCR reaction without competitor
was checked by sequencing analyses of the amplified PCR
product (results not shown). The number of cycles used in
qc-PCR was restricted to the exponential phase of the
amplification (28 cycles). The linearity of the qc-PCR
was controlled by using increasing amounts of cDNA
(0–1000 ng). We compared the matrilin-3 mRNA values
obtained from normal cartilage and from cartilage with
minor and severe lesions, using a non-parametric statistic
test (Mann–Whitney U-test). All data are presented as
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duplicates. Significant differences were defined as P<0.05.ResultsFig. 2. Distribution of matrilin-3 in normal cartilage/bone sections (A) and sections with mild (B), moderate (C), and severe (D) osteoarthritic
lesions. Sections were obtained from femoral load-bearing area and incubated with an affinity purified polyclonal antibody against matrilin-3.
Note that the zonal matrilin-3 expression varies from normal to osteoarthritic stages. The territorial deposition of matrilin-3 increases in
moderate and severe OA (bar=250 m).Fig. 3. Localization of matrilin-3 in normal cartilage (bar=100 m). (A) Immunostaining using a polyclonal antibody against matrilin-3.
Matrilin-3 deposition is visible in the tangential zone and subchondral bone. (B) Focal expression of matrilin-3 mRNA is visible in
chondrocytes of the tangential zone and the upper middle zone. (C) In situ hybridization using the matrilin-3 sense probe as a negative
control. (D) Positive control in situ hybridization using the digoxigenin-labeled 28S mRNA probe.PROTEIN AND mRNA LOCALIZATION OF MATRILIN-3 IN NORMAL AND
OSTEOARTHRITIC CARTILAGE/BONE
Normal and osteoarthritic cartilage samples were taken
from the load bearing area of femoral condyles. Enzymatic
pretreatment of the paraffin embedded tissue with
hyaluronidase/pronase enhanced staining intensity for
matrilin-3 and was therefore used on all tissue sections
processed for immunohistochemistry. In all specimens from
both normal and osteoarthritic tissue, matrilin-3 depositionswere observed (Fig. 2). In normal cartilage, several layers
can be separated by morphological criteria. The lamina
splendens, a thin layer directly facing the articular joint
space is followed by the tangential, middle, deep, and
calcified cartilage zone. Below, the subchondral bone with
the bone trabeculae is found. In sections of normal carti-
lage [Figs 2(A) and 3(A)] the lamina splendens, the tangen-
tial and the upper middle zones were stained. Matrilin-3
staining was diffusely distributed in the cartilage matrix, no
cellular staining was detectable. In general, staining inten-
sity was faint. In the lower middle zone, the deep zone, and
the calcified zone no matrilin-3 deposition was detectable.
In subchondral bone trabeculae and in the osteocytes
within newly formed osteoid, matrilin-3 staining was
present.
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(Mankin score 1–4) the zonal organization is intact, how-
ever, the articular surface is fibrillated, with small clefts
reaching down to the tangential zone. In these samples
(N=10), matrilin-3 deposition was concentrated in the
middle zone with some staining seen also in the upper
deep zone [Fig. 2(B)]. In bone, cells lining the subchondral
bone trabeculae and osteocytes stained positive [Fig. 6(A)].
Staining for matrilin-3 in cartilage increased in correlation
with the severity of the osteoarthritic lesions. In samples
with moderate OA (Mankin score 5–8), the tangential zone
is absent. Again, matrilin-3 was most prominent in the
middle zone and in the upper deep zone [Fig. 2(C)]. In
comparison to samples with mild osteoarthritic lesions, the
staining intensity increased. In addition to a diffuse inter-
territorial staining, a strong territorial staining was visible in
the middle and upper deep zone [Fig. 4(A)]. In stages with
severe matrix degeneration (Mankin score >8), the upper
middle zone was mostly absent and clefts reached down to
the deep zone [Figs 2(D) and 5(A)]. Matrilin-3 deposition
was detectable in the upper deep zone, again no staining
was visible in the lower deep and calcified zone [Figs 2(D)
and 5(A)]. The extracellular matrix stained in a diffuse
pattern and focally a cellular staining was observed. In
general, matrilin-3 deposition within the extracellular carti-
lage matrix was diminished or absent in the cartilage zone
adjacent to the articular joint space, independent of the
osteoarthritic defects.
To complement the immunohistochemical results
the distribution of matrilin-3 mRNA was determined.
Chondrocytes expressing matrilin-3 could be detected in all
cartilage samples. In normal cartilage, matrilin-3 mRNA
was restricted to chondrocytes of the articular surface and
of the upper middle zone [Fig. 3(B)] and the signal intensity
was low. To exclude degradation and loss of mRNA during
decalcification and fixation, samples were incubated with
the 28S RNA probe as a positive control [Fig. 3(D)]. A
negative control with the matrilin-3 sense probe in com-
parable labeling efficiency as the anti-sense probe failed to
detect any hybridization signal [Fig. 3(C)]. In normal
cartilage/bone sections a signal was detected in all
nucleated cells. In cartilage samples showing mild,moderate, or severe osteoarthritic lesions, matrilin-3 mRNA
expression correlated with the observed protein deposition
and the signal intensity was increased as compared to
normal samples. Cartilage with mild or moderate osteo-
arthritic lesions showed a preferred matrilin-3 mRNA syn-
thesis in the middle cartilage zone. In serial sections of the
same region, a distinct matrilin-3 mRNA expression is
visible [Fig. 4(B)].
In addition to the correlated expression of mRNA and
protein, proliferating chondrocytes near the articular joint
space showed mRNA expression with no or weak protein
deposition [Fig. 5(B), arrows].
In bone, matrilin-3 protein deposition was correlated with
matrilin-3 gene expression. Bone cells lining the bone
trabeculae as well as osteocytes within the new-formed
osteoid contained matrilin-3 mRNA [Figs 6(A), (B)]. In bone
cells, the signal intensity was unchanged between normal
and osteoarthritic samples. Tibia samples were also
analysed and demonstrated no significant differences in the
staining pattern compared to the femoral samples (results
not shown). When using a second mRNA probe directed
against a different portion of the matrilin-3 transcript, an
identical distribution pattern was detected (results not
shown). Hybridization of osteoarthritic samples with the
sense probe showed no hybridization signal (data not
shown).Fig. 4. Matrilin-3 in cartilage/bone sections from patients with moderate osteoarthritic lesions. (A) Serial cartilage/bone sections were
incubated with a polyclonal antibody against matrilin-3. Chondrocytes from the middle cartilage zone show a prominent deposition of
matrilin-3 within the territorial matrix (bar=100 m). (B) Corresponding in situ hybridization for detection of matrilin-3 mRNA. Incubation with
a digoxigenin-labeled matrilin-3 riboprobe followed by immunological detection and substrate staining gives signals in the chondrocytes of
the middle cartilage zone.QUANTITATIVE DETERMINATION OF MATRILIN-3 mRNA IN NORMAL
AND OSTEOARTHRITIC CARTILAGE
Quantification of matrilin-3 mRNA in normal and osteo-
arthritic cartilage was carried out using defined serial
dilutions of competitor (0.6 fg to 156 fg). The linearity of the
assay was controlled using a constant amount of competi-
tor (156 fg) and increasing amounts of cDNA (10–1000 ng).
A linear correlation was obtained between 50 and 500 ng
for cDNA from normal cartilage and between 50 and 750 ng
for cDNA from osteoarthritic cartilage (results not shown).
In five normal samples, a mean value of 0.85 fg/ng mRNA
was determined by qc-PCR [Fig. 7(B)], while the mean
value in chondrocytes from tissue with minor osteoarthritic
Osteoarthritis and Cartilage Vol. 10, No. 4 259lesions was 12.9 fg/ng mRNA. In samples with severe
osteoarthritic lesions the mean level of matrilin-3 mRNA
was 32 fg/ng mRNA. Thus, matrilin-3 mRNA amounts were
significantly increased in severely osteoarthritic samples as
compared to samples with minor lesions (P=0.0095,
Mann–Whitney U-test).Fig. 5. Distribution of matrilin-3 in cartilage/bone section from end stage osteoarthritis with severe lesions of the articular surface. (A)
Immunohistochemical localization, using a polyclonal antibody against matrilin-3. Protein deposition is concentrated to the upper deep
cartilage zone. (B) In situ hybridization using a 785 bp digoxigenin labeled riboprobe for matrilin-3. Matrilin-3 mRNA expression correlates
with the protein pattern. Proliferating chondrocytes, near the articular joint space show mRNA expression without pronounced protein
deposition in the surrounding extracellular matrix (arrows).Fig. 6. Matrilin-3 expression in subchondral bone (bar=100 m). (A) Decalcified cartilage/bone paraffin sections (minor osteoarthritic lesions)
were incubated with a polyclonal antibody against matrilin-3. Matrilin-3 deposition is visible in osteogenic cells lining the subchondral bone
trabeculae and in the adjacent osteocytes. (B) Corresponding in situ hybridization. A serial section was incubated with a digoxigenin-labeled
riboprobe for matrilin-3 mRNA. Matrilin-3 mRNA expression correlates with protein deposition.ANALYSIS OF MATRILIN-3 IN NORMAL AND OSTEOARTHRITIC
CARTILAGE EXTRACTS BY IMMUNOBLOTS
Purified cartilage extracts were analysed under reducing
and non-reducing conditions on a 4–22% SDS-PAGE gel,
followed by Western blotting using an affinity purified poly-
clonal antibody against matrilin-3. Under non-reducing con-
ditions, a complex band pattern was seen in samples fromhealthy donors as well as in osteoarthritic cartilages [Fig.
8(C)]. Higher oligomeric forms migrated above 200 kDa,
presumably representing tetrameric and trimeric molecules
that in part also contain subunits of matrilin-110,21–23.
Further, two bands around 60 kDa represent intact and
slightly degraded matrilin-3 subunits. Indeed, in matrilin-4 a
cleavage site was recently located in the linker between the
second vWFA-like domain and the coiled-coil domain24. A
sequence with homology to that at which matrilin-4 is
cleaved is present in matrilin-3 between the fourth EGF-like
domain and the coiled coil domain. Under reducing con-
ditions, a single band at around 70 kDa appears that
presumably represents both the processed and the unpro-
cessed monomers, which are not resolved under reducing
conditions [Fig. 8(D)]. The degraded forms of matrilin-3 are
260 O. Pullig et al.: Matrilin-3 in human articular cartilagemore prominent in osteoarthritic than in healthy cartilage.
The comparable loading of individual lanes was checked by
reversible staining of blotted proteins with Ponceau red
[Fig. 8(A),(B)].Fig. 7. Competitive quantitative PCR analysis of the matrilin-3 mRNA. (a) Representative results of the competitive quantitative PCR. cDNA
of normal (N) and osteoarthritic (OA) cartilage was amplified in the presence of defined amounts of competitor DNA (0.6 fg to 156 fg). 10 l
of the PCR products were size fractionated in an agarose gel containing ethidium bromide. The amounts of matrilin-3 fragment (upper band)
and the competitor fragment (lower band) were quantified by video densitometry, set in relation, and plotted versus the amount of competitor.
The amounts of matrilin-3 cDNA in the normal samples (h) and in the osteoarthritic samples (m) were calculated from the equivalence point
(log 0). (b) Quantification of matrilin-3 mRNA in normal cartilages (N=4) and in cartilages with moderate osteoarthritic lesions (N=6) and
severe osteoarthritic lesions (N=6). Matrilin-3 mRNA is significantly increased in osteoarthritic cartilage samples as compared to normal and
in samples with moderate lesions as compared to such with severe lesions (P=0.0095, Mann–Whitney-U Test).Discussion
Only limited information has been available on the local-
ization and expression of matrilin-3 in adult human carti-
lage. Expression has been demonstrated in chondrocytes
of the mouse epiphyseal growth plate and a function in the
skeletal development has been proposed10. Proteins with
a restricted expression in the growing cartilage of the
epiphyseal growth plate characterize certain chondro-
cyte differentiation stages with a defined phenotype.
Interestingly, it has been shown that matrix components of
the growth plate are often re-expressed under the patho-
logical conditions in osteoarthritis. This applies not only to
type X collagen, alkaline phosphatase, osteocalcin, and
osteopontin15,16,25,26, but, as we report here, also to
matrilin-3. However, matrilin-3 is expressed at low levels
also in normal human articular cartilage.
In normal cartilage, matrilin-3 has a restricted deposition
within the transition of the superficial layer and the middle
cartilage zone. Matrilin-3 expression, as shown by quanti-
tative RT-PCR, in situ hybridization, immunohistochemistry
and immunoblots, correlates with the progression of carti-
lage degeneration. Interestingly, matrilin-3 deposition is notlimited to a certain zone in cartilage, but it is restricted
within a defined distance of about 100 to 200 m from the
articular joint space (Fig. 2). The staining pattern we
observe is pericellular, indicating a function of matrilin-3 in
preserving the pericellular environment. Also, type VI col-
lagen is preferentially deposited in the pericellular capsule
and the pericellular matrix and is therefore thought to be
involved in protective structures serving to withstand the
mechanical forces of the extracellular cartilage matrix27.
On the structural level, both, matrilin-3 and type VI collagen
contain vWFA-like domains. Members of the vWFA-domain
superfamily have different functions in cell differentiation,
cell migration, cell adhesion, hemostasis, and immune
response, but share common characteristics in their partici-
pation in cell–cell and cell–matrix interactions (reviewed in
Colombatti and Bonaldo28). In analogy to type VI collagen,
matrilin-3 has been shown to be deposited in pericellular
meshworks around rat chondrosarcoma cells and in mouse
sternal and tracheal cartilages10. Matrilin-3 or matrilin-3
containing filaments may be anchored via interactions
with cells or with extracellular components. The inter-
actions of matrilin-3 have not yet been studied, but the
structurally related matrilin-1 has been shown to bind to
11 integrin29 as well as to cartilage proteoglycans30,31,
type II collagen32, and itself22.
Our results show a low but significant expression of
matrilin-3 mRNA in normal human cartilage, which is highly
upregulated in osteoarthritic cartilage. For matrilin-1, a
low or minimal expression has been observed in normal
Osteoarthritis and Cartilage Vol. 10, No. 4 261Fig. 8. SDS-PAGE and immunoblot for matrilin-3 of extracts of normal and osteoarthritic cartilage 15 g of partially purified extracts of normal
(lane 1, 2) and osteoarthritic (lane 3, 4) cartilage were separated by SDS-PAGE in a 4–22% polyacrylamide gel under non-reducing (A), (C)
or reducing (B), (D) conditions. Proteins were visualized by Ponceau red staining (A), (B) to show equal loading or with immunoblot with an
affinity purified antibody against matrilin-3.human articular cartilage using immunohistochemical
methods13,14. In OA, matrilin-1 deposition increases and
the immunohistological staining is more pronouncedly cel-
lular and pericellular, with low or absent staining of the
interterritorial matrix14. Together with our data on matrilin-3
deposition and synthesis, a coexpression of matrilin-1 and
matrilin-3 in hetero-oligomers in the cellular environment is
likely and may indeed be due to the two types of matrilin
subunits occurring in hybrid oligomers10,21–23 or in hybrid
filaments.
Data on the functional role of matrilin-3 in cartilage are
limited but from deletion analysis in cell culture, there is
evidence that vWFA-like domains enables interactions with
cellular or extracellular components10,21,22. So far, no bind-
ing partners for matrilin-3 have been identified in vivo
except the formation of matrilin-3 homomers and
heteromers with matrilin-110,21,22. Through expression
analysis in developing mouse joints, matrilin-3 was shown
to be an integral component of developing cartilage. In the
growth plate, expression was observed in the resting carti-
lage zone as well as in the proliferating and hypertrophic
zones, implicating that matrilin-3 participates in cartilage
development. In contrast, in mouse articular cartilage
matrilin-3 is present in lower amounts and deposit only atthe periphery of the joints. This is in agreement with our
results showing low expression in the superficial cartilage
zone of normal human articular cartilage. In OA, along with
an enhanced disintegration of the cellular microenviron-
ment matrilin-3 is gradually lost from the territorial matrix.
This indicates that the structural organization is destroyed
and a pericellular anchoring of matrilin-3 is reduced. This
may in part be due to an increased proteolysis of matrilin-3
in osteoarthritic cartilage. In parallel, there is an increase in
matrilin-3 synthesis. Chondrocyte maturation and hyper-
trophy during development is regulated by factors such as
Indian hedgehog protein, PTH-related peptide, the group of
bone morphogenic proteins and members of the fibroblast
growth factor family. There is evidence, that these proteins
influence the differentiation and hypertrophy of chondro-
cytes also in osteoarthritis and therefore may contribute to
matrilin-3 up-regulation. In comparison to the strict regu-
lation of cellular differentiation and activation during
embryonal development, the chondrocyte biosynthetic
activity in OA is unbalanced, resulting in a matrix which is
unable to withstand the physiological mechanical forces.
The low expression of matrilin-3 in normal cartilage and
the correlation of tissue damage with the induction of
matrilin-3 expression shows that matrilin-3 may be used as
262 O. Pullig et al.: Matrilin-3 in human articular cartilagea marker for the progression of OA. Studies on the function
of matrilin-3 in cartilage as well as the determination of
matrilin-3 in body fluids would be helpful in understanding
and monitoring the disease process of OA.Acknowledgments
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